HER2-Positive NSCLC Yields to Targeted Agents (CME/CE)
(MedPage Today) -- A majority of patients with HER2-positive lung cancer had objective responses or stable disease when they received anti-HER2 agents in addition to chemotherapy, a small clinical study showed.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | HER2 | Lung Cancer | Non-Small Cell Lung Cancer | Primary Care | Study